FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102581021> ?p ?o ?g. }

• W2102581021 endingPage "308" @default.
• W2102581021 startingPage "303" @default.
• W2102581021 abstract "Varicose veins and the complications of venous disease are thought to affect over a quarter of the adult population and the management of these conditions are a major cause of health service expense. Advances in the understanding of venous pathophysiology have highlighted numerous potential targets for pharmacotherapy. This review considers the evidence for pharmacological agents used for the treatment of chronic venous disease. A literature search using Pubmed, Embase and Cinahl databases was performed. The initial search terms 'varicose vein', 'venous ulcer' and 'venous disease' were used with appropriate search limits to identify prospective studies of pharmacotherapy in venous disease. A wide range of venoactive and non-venoactive drugs have been studied in patients with venous disease. The use of micronized purified flavonoid fraction (Daflon) can reduce symptoms of pain, heaviness and oedema in patients with venous reflux and a recent meta-analysis concluded that Daflon improves healing in patients with venous ulceration treated with compression. Pentoxifylline may be a useful adjunct to compression therapy for patients with venous ulceration. Oxerutins and calcium dobesilate may be of benefit in reducing oedema and rutosides may help to relieve the symptoms of varicose veins in pregnancy. The clinical benefits of other medications remain unproven. Although numerous pharmacological agents have been proposed and studied, Daflon has demonstrated the greatest clinical benefits in patients with venous disease. Further research is needed to define the role of venoactive drugs in clinical care and improve our understanding of the pathophysiology of venous disease to help identify new therapeutic avenues." @default.
• W2102581021 created "2016-06-24" @default.
• W2102581021 creator A5033505510 @default.
• W2102581021 creator A5083597143 @default.
• W2102581021 date "2009-07-01" @default.
• W2102581021 modified "2023-09-28" @default.
• W2102581021 title "Pharmacological Agents in the Treatment of Venous Disease: An Update of the Available Evidence" @default.
• W2102581021 cites W1486729502 @default.
• W2102581021 cites W153583291 @default.
• W2102581021 cites W1560585987 @default.
• W2102581021 cites W168083411 @default.
• W2102581021 cites W1771870177 @default.
• W2102581021 cites W189385333 @default.
• W2102581021 cites W1906890694 @default.
• W2102581021 cites W1970925332 @default.
• W2102581021 cites W1981843902 @default.
• W2102581021 cites W1982423948 @default.
• W2102581021 cites W1989988743 @default.
• W2102581021 cites W1991582820 @default.
• W2102581021 cites W1991629212 @default.
• W2102581021 cites W1992585421 @default.
• W2102581021 cites W1993357017 @default.
• W2102581021 cites W1999880474 @default.
• W2102581021 cites W2000841294 @default.
• W2102581021 cites W2003739804 @default.
• W2102581021 cites W2006451036 @default.
• W2102581021 cites W2007841048 @default.
• W2102581021 cites W2015385497 @default.
• W2102581021 cites W2018093749 @default.
• W2102581021 cites W2019477979 @default.
• W2102581021 cites W2021904895 @default.
• W2102581021 cites W2029572400 @default.
• W2102581021 cites W2031247251 @default.
• W2102581021 cites W203468500 @default.
• W2102581021 cites W2034957286 @default.
• W2102581021 cites W2054552132 @default.
• W2102581021 cites W2064027649 @default.
• W2102581021 cites W2082141158 @default.
• W2102581021 cites W2083117472 @default.
• W2102581021 cites W2083728618 @default.
• W2102581021 cites W2102346773 @default.
• W2102581021 cites W2123219320 @default.
• W2102581021 cites W2128088799 @default.
• W2102581021 cites W2129397054 @default.
• W2102581021 cites W2133066949 @default.
• W2102581021 cites W2140363580 @default.
• W2102581021 cites W2141486920 @default.
• W2102581021 cites W2145286057 @default.
• W2102581021 cites W2145331779 @default.
• W2102581021 cites W2161953275 @default.
• W2102581021 cites W2167748884 @default.
• W2102581021 cites W2170007149 @default.
• W2102581021 cites W2322058803 @default.
• W2102581021 cites W2341133174 @default.
• W2102581021 cites W2395424835 @default.
• W2102581021 cites W2413605752 @default.
• W2102581021 cites W2425668030 @default.
• W2102581021 cites W2474826470 @default.
• W2102581021 cites W36933924 @default.
• W2102581021 cites W8894131 @default.
• W2102581021 doi "https://doi.org/10.2174/157016109788340758" @default.
• W2102581021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19601855" @default.
• W2102581021 hasPublicationYear "2009" @default.
• W2102581021 type Work @default.
• W2102581021 sameAs 2102581021 @default.
• W2102581021 citedByCount "66" @default.
• W2102581021 countsByYear W21025810212012 @default.
• W2102581021 countsByYear W21025810212013 @default.
• W2102581021 countsByYear W21025810212014 @default.
• W2102581021 countsByYear W21025810212015 @default.
• W2102581021 countsByYear W21025810212016 @default.
• W2102581021 countsByYear W21025810212017 @default.
• W2102581021 countsByYear W21025810212018 @default.
• W2102581021 countsByYear W21025810212019 @default.
• W2102581021 countsByYear W21025810212020 @default.
• W2102581021 countsByYear W21025810212021 @default.
• W2102581021 countsByYear W21025810212022 @default.
• W2102581021 countsByYear W21025810212023 @default.
• W2102581021 crossrefType "journal-article" @default.
• W2102581021 hasAuthorship W2102581021A5033505510 @default.
• W2102581021 hasAuthorship W2102581021A5083597143 @default.
• W2102581021 hasConcept C126322002 @default.
• W2102581021 hasConcept C141071460 @default.
• W2102581021 hasConcept C177713679 @default.
• W2102581021 hasConcept C2776106345 @default.
• W2102581021 hasConcept C2777475103 @default.
• W2102581021 hasConcept C2778230777 @default.
• W2102581021 hasConcept C2779134260 @default.
• W2102581021 hasConcept C2910471476 @default.
• W2102581021 hasConcept C500440147 @default.
• W2102581021 hasConcept C71924100 @default.
• W2102581021 hasConceptScore W2102581021C126322002 @default.
• W2102581021 hasConceptScore W2102581021C141071460 @default.
• W2102581021 hasConceptScore W2102581021C177713679 @default.
• W2102581021 hasConceptScore W2102581021C2776106345 @default.
• W2102581021 hasConceptScore W2102581021C2777475103 @default.
• W2102581021 hasConceptScore W2102581021C2778230777 @default.
• W2102581021 hasConceptScore W2102581021C2779134260 @default.

• next